Speakers
Interim President and Chief Executive Officer, Synlogic
Aoife is Chief Medical Officer at Synlogic Inc., where she leads clinical development, operations, and regulatory affairs. Previously she was VP and Head of the Rare Disease Innovation Unit at Biogen where her work resulted in the approval of ALPROLIXTM, ELOCTATETM and SPINRAZATM...
Read More →
Deputy Director, Division of Rare Diseases Research Innovation, National Center for Advancing Translational Sciences (NCATS), NIH, United States
Philip J. (P.J.) Brooks is the deputy director of NCATS’ Division of Rare Diseases Research Innovation. Brooks represents NCATS in the NIH-wide Gene Therapy Working Group, the Regenerative Medicine Innovation Project and the International Rare Diseases Research Consortium (IRDiRC...
Read More → ZK
Executive Vice President, Clinical Development and Translational Medicine, Finch Therapeutics Group
Dr Zain Kassam is a Co-founder and Executive VP, Clinical Development & Translational Medicine at Finch Therapeutics Group, a microbiome therapeutics spin out of OpenBiome, the world’s first stool bank for fecal transplants. He is also a founding team member and former CMO at OpenBiome...
Read More → TK
Regulatory Biologist, Office of Vaccines Research and Review, CBER, USFDA
Dr. Taruna Khurana did her doctoral research in Cell and Molecular Biology at University of Cologne, Germany, followed by postdoctoral fellowships at NIH and FDA. She had joined the Office of Vaccines Research and Review, CBER, FDA as a Research Reviewer in 2009. Currently, she is...
Read More →
Monday June 25, 2018 3:00pm - 4:15pm EDT
Room 156ABC
Boston Convention and Exhibition Center 415 Summer Street, Boston, MA 02210 USA